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Background: There is limited data regarding factors influencing the respiratory outcome at
school age of ex-preterms born since the introduction of antenatal steroids, surfactant
replacement together with less aggressive ventilation.
Objectives: To establish the main antenatal, neonatal and early childhood respiratory corre-
lates of respiratory status in school-aged children born at 32weeks of gestation.
Methods: Ex-preterm children born at 32weeks of gestation between 1997 and 2001 at
Bordeaux University Hospital were evaluated at school age, using a respiratory questionnaire
and lung function tests (spirometry, plethysmography, exercise challenge test and CO lung
diffusing capacity DLCO measurements). Factors associated with lung function were investi-
gated using polynomial regression analyses.
Results: Of the 151 included children [mean age: 8.6  0.8 years; mean gestational age,
30.1  1.7 weeks; mean birth weightZ 1310  380 g; 68.2% ventilated at birth; 46.4% treated
with surfactant; 36.4% with prior bronchopulmonary dysplasia (BPD)], 47% presented obstruc-
tive lung abnormalities, 11% restrictive or mixed lung abnormalities, 41% exercise-inducedRespiratoire, Hoˆpital Pellegrin, Place Ame´lie Raba-Le´on, F-33000 Bordeaux, France. Tel.:þ33 5 56 79
oun@u-bordeaux2.fr (M.-L. Choukroun).
3 Elsevier Ltd. All rights reserved.
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Pulmonary outcome correlates after preterm birth 1967bronchoconstriction, and 15.5% reduced DLCO. Surfactant therapy was independently associ-
ated with a lower risk of lung abnormalities (p < 0.05). The association between BPD and lung
abnormalities at school age was not significant, but prior BPD increased the risk of restrictive
or mixed abnormalities (odds ratio: 6.11, confidence interval [1.1; 33.99]). Early childhood res-
piratory events were not associated with the occurrence of lung abnormalities.
Conclusion: Children born at 32 weeks of gestation remain at risk for impaired lung function
at school age in particular when they did not receive surfactant. Restrictive or mixed lung de-
fects are mainly associated with prior BPD.
ª 2013 Elsevier Ltd. All rights reserved.Introduction
Progress in neonatal care has resulted in increased survival
rates in very preterm (VP) and very low birth weight (VLBW)
infants. The incidence of bronchopulmonary dysplasia
(BPD) remains stable, although BPD pathophysiology has
evolved. The “old” form affected slightly preterm new-
borns with a respiratory distress syndrome (RDS) exposed to
aggressive mechanical ventilation and high FIO2. It resulted
from lung injuries occurring during the saccular phase of
lung development and was characterized by lung fibrosis,
airway obstruction and airway inflammation. Nowadays,
the most common “new” form of BPD results from an
earlier (canalicular) phase disorder leading to alveolarisa-
tion and vascular lung development impairments [1,2]. This
“new” form is defined by the National Institute of Child
Health and Human Development (NICHD) as the need for
supplemental oxygen for at least 28 days after birth, and its
severity is graded according to the oxygen requirements at
36 weeks postmenstrual age (PMA) [3].
Cohort studies have shown that preterm birth may be
associated with a poor respiratory outcome during infancy
and childhood [4]. Adolescents and young adults with the
“old” BDP showed reduced airflow, air trapping, bronchial
hyper-responsiveness (BHR) and reduced exercise capacity
[5e7]. The outcome of the “new” BPD has also been a
subject of interest. More and more studies are now avail-
able regarding respiratory outcome in extremely preterm
neonates. Recently, data obtained from the follow-up of
the EPICure cohort indicated that “after extremely preterm
birth impaired lung function and increased respiratory
morbidity persist into middle childhood, especially among
those with BPD” [8]. Obstructive lung abnormalities,
reduced exercise capacity and impaired ventilatory adap-
tation during maximum exercise have been reported in this
population at the age of 11 years [9e11]. Noteworthy, less
data are available regarding the long-term outcome of in-
termediate and late prematurity. Recent reports showed
that respiratory morbidity and impairment of lung function
in infants born at 32e36 weeks of gestational age (GA) were
comparable with those reported in VP infants [12,13].
Moreover, there is now evidence that reduced lung function
during childhood may persist into adulthood [14]. The long-
term respiratory outcome after preterm birth is most likely
due to an interaction between the neonatal history and the
environment, but the main determinants are not clearly
established. The aim of this study was to describe the
respiratory status in school-aged children born at 32weeks of gestation and to analyse its antenatal, neonatal
and early childhood respiratory correlates.
Materials and methods
Study design and subjects
The study population was a retrospective cohort including
all the children born with a GA 32 weeks between 1997
and 2001 at the Bordeaux University Hospital (France). The
medical records were reviewed in 2006. All the survivors
without congenital abnormalities or major neurological
involvement were eligible to participate in the study.
Exclusion criteria were the following: children with cogni-
tive impairment, physical limitation due to cerebral palsy,
major surgery during childhood, or with additional comor-
bidity which may contribute to respiratory morbidity as
severe reflux, dysfunctional swallowing, cardiovascular
malformation, etc. However, episodic wheezing, acute
viral bronchiolitis during infancy and asthma were not
considered to be exclusion criteria.
Between 2006 and 2008, after informed consent from the
parents and the assent of the children had been obtained,
the participants were seen by a pediatrician for physical
examination, respiratory questionnaire administration and
lung function tests (LFT) were performed. The study was
approved by the Bordeaux Hospital Ethics Committee.
Collected data
Antenatal and neonatal data e gender, GA, birth weight
(BW), parity, maternal smoking and morbidity during
pregnancy, antenatal steroids, premature rupture of
membranes (PROM), chorioamniotitis, mode of delivery,
clinical Risk Index for Babies (CRIB) score [15], intrauterine
growth retardation (IUGR), RDS, mechanical ventilation
modalities, exogenous surfactant administration, supple-
mental oxygen therapy, patent ductus arteriosus (PDA),
necrotizing enterocolitis, BPD, postnatal steroids e were
collected retrospectively from the medical records. BPD
was defined as the need for oxygen supplementation to
obtain 92e94% oxygen saturation at 28 days according to
the NICH definition [3]. BPD was considered mild when
there was no O2-dependency at 36 weeks PMA or discharge,
moderate when O2 supplementation at 36 weeks PMA was
0.21 < FIO2 < 0.30, severe when FIO2  0.30 and/or positive
pressure at 36 weeks PMA or hospital discharge.
Study population
444 preterm infants (  32 weeks GA) 
born between 1997-2001 
Neonatal death :
43 (10%) 
Excluded children: 250 (56%)
- Lost to follow up: 165 (37%) 
- Parental or child refusal: 57 (13%) 
- Neurological, cardiac impairments: 28 (6%)
Enrolled children :
151 (34%) 
Figure 1 Study population.
1968 M.-L. Choukroun et al.Respiratory events during infancy and early childhood e
a family history of atopy, respiratory illnesses, respiratory
symptoms (nocturnal cough, exercise-induced cough,
wheezing, dyspnoea at rest, exercise-induced dyspnoea),
hospitalisation for asthma exacerbation, asthma medica-
tion use, specialist visits, physician diagnosed allergies
(eczema, hay-fever, food allergy), parental smoking and
home environment (home pet exposure.) e were
collected from the respiratory questionnaire. Wheezing
episodes were categorised according to: “ever wheeze”
when wheezing had been reported at any time in the past,
“current wheeze” when wheezing had been reported
within the previous 12months. Asthma diagnosis was based
on physician reports and/or use of asthma medication.
Lung function tests
They included: spirometry, plethysmography, airways re-
sistances (raw), CO diffusing capacity (DLCO) measure-
ments, exercise testing challenge, and bronchodilator (BD)
testing (see Online Supplement)
Baseline spirometry lung function data were expressed
as percentages of the predicted values obtained from the
Zapletal reference equations [16] according to the ERS 1993
recommendations [17] and corresponding z-scores.
Spirometry was normal when FEV1 was 88% predicted,
FEF25e75  65% predicted, PEF  60% predicted, lung vol-
umes between 80% and 120% predicted and Raw  140%
predicted. Respiratory abnormalities were classified as
obstructive with or without hyperinflation, restrictive or
mixed [18]. An obstructive defect was defined by TLC  80%
predicted, and FEV1 < 88% predicted or FEV1/FVC < 80%
predicted or FEF25e75 < 65% predicted or RV/TLC > 120%
predicted, or Raw > 140% predicted. A restrictive defect
was defined by TLC < 80% predicted and FEV1/VC  80%
predicted, and a mixed defect by TLC < 80% predicted and
FEV1/VC < 80% predicted. Exercise-induced bronchocon-
striction (EIB) was defined as a fall 12% in FEV1, or 35% in
FEF25e75, or 40% in FEF, or an increase 20% in RV or RV/
TLC or 35% in Raw after exercise. An increase 12% in
FEV1, or 35% in FEF25e75, or a decrease 20% in RV or RV/
TLC or 35% in Raw from the baseline values 10 min after
BD administration defined significant reversibility of the
obstruction. DLCO was expressed as percentages of the
values calculated from the reference equations established
by Rouatbi et al [19].
Statistical analysis
Results are expressed as means (SD) or medians [minmax]
or n (%) as appropriate. Differences between subgroups were
assessed by Chi-square or Fisher’s exact tests for categorical
variables and by Student’s t-tests or Wilcoxon tests, analysis
of variance (Anova) or KruskalleWallis tests for continuous
variables. A p value <0.05 was considered to be statistically
significant for all the tests.
Univariable and multivariable polynomial regression
analyses were performed to explore the factors associated
with the lung function abnormalities at school-age. The
variables associated with lung function abnormalities with
a p value 0.2 in the univariable analysis were included ina multivariable model and then selected using a backward
stepwise strategy, through using a threshold of 5%. The
variables: BPD, intrauterine growth retardation (IUGR) and
GA were forced into this model. The construction of the
multivariable model was conducted among the subset of
the initial sample with no missing data on any variable of
interest. All statistical analyzes were performed with SAS
software, version9.1 (SAS Institute, Cary, NC, USA).Results
Study population
Out of a total of 444 eligible children born with a GA 32
weeks, 151 were enrolled into the study (Fig. 1). Their
antenatal and neonatal characteristics are given Table 1:
Caesarean section, antenatal steroids and necrotizing
enterocolitis were more frequent in the participants
whereas maternal smoking during pregnancy, PROM, RDS
with mechanical ventilation and patent ductus arteriosus
(PDA) were more frequent in the excluded surviving chil-
dren. Data on maternal smoking during pregnancy were
available in only 254 children (40% of the excluded surviving
children and 88% of the participants, respectively). The
incidence and severity of BPD were not different between
the groups.Baseline characteristics of the ex-preterm children
at school-age
The demographic characteristics and childhood respiratory
morbidity of the participants were compared according to
prior BPD status (Table 2). Moderate and severe BPD sub-
groups (n Z 8 and 6, respectively) were pooled together
due to their small sample size. The children with prior BPD
were significantly more premature and of smaller birth
weight (BW) compared to the non-BPD group. Those with
prior moderate/severe BPD were initially more markedly
premature and of smaller BW than the others and at school
Table 1 Neonatal and perinatal characteristics of the study population born at 32 weeks of gestation, in 1997e2001,
Bordeaux, France.
All patients Excluded patients Excluded surviving
patients
Included patients
N 444 293 250 151
Delivery data
Multiple births 125/440 (28.2) 78/290 (26.6) 65/247 (26.0) 47/150 (31.1)
Maternal morbidity 44/420 (9.9) 27/273 (9.2) 22/233 (9.0) 17/147 (11.3)
Maternal morbidity during pregnancy 329/440 (74.0) 220/289 (75.0) 194/247 (77.6) 109/151 (72.2)
Caesarean section 301/444 (67.8) 187/293 (63.8)* 85/250 (34.0) * 114/151 (75.5)
Antenatal steroids 223/436 (50.2) 133/289 (45.4) ** 119/247 (48.0) ** 90/148 (60.0)
Premature rupture of membranes 142/443 (32.0) 102/292 (34.9) 91/249 (36.5)* 40/151 (26.5)
Chorioamnionitis 190/442 (42.8) 129/292 (44.0) 109/249 (43.6) 61/150(40.4)
Smoke exposure during pregnancy 85/254 (33.4) 55/121 (45.5) *** 44/100 (44.0) *** 30/133 (22.6)
Neonatal characteristics
Gestational age (wks) 29.7 (1.9) 29.6 (2.0)* 29.8 (1.8) 30.1 (1.7)
Birth weight (g) 1310.5 (378.4) 1287.5 (376.3) 1331 (362.5) 1355 (379.6)
Sex ratio (male:female) 1.39:1 1.31:1 1.31:1 1.56:1
CRIB 1 [0e18] 1 [0e18]* 1 [0e13] 1 [0e14]
Respiratory distress 373/444 (84.0) 257/293 (87.7) ** 214/250 (85.6)* 116/151 (76.8)
Exogenous surfactant (ES) 240/443 (54.1) 170/292 (58.2) * 134/250 (53.6) 70/151 (46.4)
Delay for ES administration (min) 180 [5e2880] 120 [5e2880] 120 [25e2880] 180 [5e1560]
Invasive ventilation 345/443 (77.7) 242/292 (82.6) *** 199/249(79.6) ** 103/151 (68.2)
Patent ductus arteriosus 119/439 (26.8) 92/288 (31.4) ** 63 (25.2) 27/151 (17.9)
BDP 145/413 (32.7) 90/262 (30.7) 87 (34.8) 55/151 (36.4)
Mild 93/143 (64.1) 52/88 (59.1) 50/85 (58.8) 41/55 (74.5)
Moderate 30/143 (20.7) 22/88 (25.0) 22/85 (25.0) 8/55 (14.5)
Severe 20/143 (13.8) 14/88 (15.9) 13/85 (15.3) 6/55 (10.9)
Postnatal steroids 142/439 (32.0) 88/288 (30.0) 85/249 (34.0) 54/151 (35.8)
Necrositing enterocolitis 26/423 (5.9) 11/272 (3.8) * 7/247 (2.8) ** 15/151 (9.9)
Duration of
Invasive ventilation (d) 4 [0e300] 4 [0e300] 3 [0e99] 4 [0e99]
Non-invasive ventilation (d) 7 [0e99] 7 [0e99] 7 [0e99] 9 [0e99]
Oxygen supplementation (d) 4 [0e300] 4 [0e300] 4 [0e120] 7 [0e127]
Values expressed as mean (SD), median [min  max] or n/N(%) as appropriate.
CRIB, clinical risk index for babies; ES, exogenous surfactant; BPD, bronchopulmonary dysplasia.
*p < 0.05; **p < 0.01; ***p < 0.001: comparison between different groups vs included patients.
Pulmonary outcome correlates after preterm birth 1969age were more likely to be underweight and shorter. Sixty
percent of the participants reported more than one res-
piratory symptom during infancy and childhood. “Ever”
symptoms were wheezing in 50% of cases, exercise cough
in 18%, nocturnal cough in 17%, and hospitalisation for
asthma exacerbation in 6% (see Fig. E1 in the Online
Supplement). Eighteen percent of them were on active
asthma medication. Noteworthy, children with prior mod-
erate/severe BPD showed significantly higher resting res-
piratory rates during physical examination and reported
more “ever” respiratory symptoms, more hospitalisations
for asthma exacerbation, more visits with lung specialists,and were more frequently exposed to domestic pets than
the children without BPD.Lung function in the ex-preterm children at school-
age
Satisfactory spirometry and plethysmography were obtained
in all the 151 children, whereas exercise testing could be
performed by only 150 children. Mean baseline values (%
predicted) and z-scores are given Table 3: they showed that
lung function remained within the normal range without
Table 2 Baseline characteristics of the included school-aged children born at 32 weeks of gestation in 1997e2001,
Bordeaux, France, according to prior BPD status.
All Without BPD Mild BPD Moderate and
Severe BPD
N 151 96 41 8 þ 6 Z 14
Age (yrs) 8.6 (0.8) 8.7 (0.8) 8.5 (0.8) 8.6 (0.8)
Ratio (M:F) 1.5:1 1.5: 1 1.3: 1 3.7: 1
Body weight (kg) 28.2 (6.4) 28.7 (6.1) 28.2 (7.4) 23.8 (3.6)x,yy
Height (cm) 132 (7.8) 131 (7.5) 131 (8.2) 127 (6.9)y
HR (min1) 90.1 (12) 89.2 (12.1) 92.1 (11.3) 90.5 (14.1)
RR (min1) 19.9 (1.3) 19.8 (1.1) 19.8 (1.2) 21.4 (1.9)xx,yy
Neonatal characteristics
GA (wks) 31 [25e32] 31 [26e32] 29 [26e32] *** 28 [25e30]xx,yyy
GA  28 weeks’ PMA 29/151 (19.2) 7/96 (7.3) 12/41 (29.3)** 10/14 (71.4)x,yyy
BW (g) 1330 [570e2510] 1455 [700e2510] 1250 [740e1820]*** 845 [570e1120]xxx,yyy
BW < 1000 g 28/151 (18.5) 9/96 (9.4) 9/41 (21.9) 10/14 (71.4)xx,yyy
IUGR 30/150 (20.0) 17/96 (17.7) 9/40 (22.5) 4/14 (28.6)
Respiratory symptoms
Current, previous year
Wheezing episodes 13/148 (8.8) 9/95 (9.5) 2/40 (5.0) 2/13 (15.4)
Ever, after discharge
1 Respiratory symptom 90/151 (59.6) 50/96 (52.1) 27/41 (65.8) 13/14 (92.9)y
Wheezing without RTI 11/151 (7.3) 6/96 (6.2) 4/41 (9.8) 1/14 (7.1)
Wheezing during RTI 76/151 (50.3) 42/96 (43.7) 24/41 (58.5) 10/14 (71.4)
Number of wheezing episodes
1e2 10/146 (6.8) 6/95 (6.3) 4/39 (10.3) 0/12 (0.0)
3e5 24/146 (16.4) 14/95 (14.7) 7/39 (17.9) 3/12 (25.0)
>5 37/146 (25.3) 21/95 (22.1) 11/39 (28.2) 5/12 (41.7)
Nocturnal cough 27/151 (17.9) 19/96 (19.8) 7/41 (17.1) 1/14 (7.1)
Exercise-induced cough 28/151 (18.5) 16/96 (16.7) 11/41 (26.8) 1/14 (7.1)
Exercise-induced dyspnoea 27/150 (18.0) 13/95 (13.7) 9/41 (21.9) 5/14 (35.7)
Hospitalisation for asthma 9/151 (6.0) 3/96 (3.1) 2/41 (4.9) 4/14 (28.6) y
Current asthma treatment 27/151 (17.9) 15/96 (15.6) 8/41 (19.5) 4/14 (28.6)
Visits with specialists 63/151 (41.7) 37/96 (38.5) 15/41 (36.6) 11/14 (78.6) x, y
Pulmonologist 14/150 (9.3) 6/96 (6.2) 4/41 (9.8) 4/13 (30.8)
ENT 44/151(29.1) 25/96 (26.0) 11/41 (26.8) 8/14 (57.1)
Allergist 17/150 (11.3) 12/96 (12.5) 4/41 (9.8) 1/13 (7.7)
Allergy other than asthma 26/151 (17.2) 17/96 (17.7) 7/41 (17.1) 2/14 (14.3)
Familial atopy 71/149 (47.7) 48/95 (50.5) 18/40 (45.0) 5/14 (35.7)
Domestic pets 89/151 (58.9) 52/96 (54.2) 24/41 (58.5) 13/14 (92.9) x, y
Passive smoking 63/151 (41.7) 42/96 (43.7) 14/41 (34.1) 7/14 (50.0)
Values expressed as mean (SD), median [min  max] or n/N (%) as appropriate.
HR, heart rate; RR, respiratory rate; mean (SD) HR and RR were calculated in 150 patients.
GA, gestational age; BW, birth weight; IUGR, intrauterine growth retardation; RTI, respiratory tract infection; ENT, ears, nose, throat.
*p < 0.05, **p < 0.01,***p < 0.001: comparison mild BPD group vs without BPD group.
yp < 0.05, yy p < 0.01, yyyp < 0.001: comparison moderate þ severe BPD group vs without BPD group.
xp < 0.05, xxp < 0.01, xxxp < 0.001: comparison moderate þ severe BPD group vs mild BPD group.
Comparison tests were performed for each pair and adjusted using the step-down HolmeBonferroni method, when the p value of the
global test for the comparison between the three groups was <0.05.
1970 M.-L. Choukroun et al.significant differences according to prior BPD status. How-
ever, all the participants, showed significantly lower forced
vital capacity (FVC), FEV1, forced mid-expiratory flow
(FEF25e75), peak expiratory flow (PEF), vital capacity (VC),
total lung capacity (TLC), functional residual capacity (FRC),and higher residual volume (RV) and RV/TLC values than
predicted values (see Table E1 in the Online Supplement).
According to the ATS/ERS interpretative strategy [18], only
42% of assessed children demonstrated normal lung function,
47% showed obstructive lung abnormalities with or without
Table 3 Baseline lung function parameters of the included school-aged children born at 32 weeks of gestation, in
1997e2001, Bordeaux, France, according to prior BPD status.
All children Without BPD Mild BPD Moderate and severe BPD
N 151 96 41 14
FVC, %pred 93.9 (13.3) 94.6 (12.7) 93.7 (14.0) 89.9 (15.1)
z log10FVC 0.92 (1.83) 0.82 (1.77) 0.89 (1.82) 1.71 (2.18)
FEV1, %pred 96.9 (13.4) 98.1 (13.0) 95.7 (12.3) 92.6 (18.1)
z log10FEV1 0.45 (1.49) 0.31 (1.45) 0.53 (1.32) 1.13 (2.04)
FEV1/FVC, %pred 98.6 (8.0) 99.3 (6.7) 98.2 (10.2) 95.5 (9.7)
z FEV1/FVC 0.26 (1.49) 0.14 (1.24) 0.34 (1.86) 0.84 (1.8)
FEF25e75, %pred 82.8 (19.8) 83.7 (19.2) 82.8 (19.6) 77.1 (24.8)
z FEF25e75 0.59 (0.67) 0.57 (0.66) 0.58 (0.65) 0.75 (0.8)
PEF, %pred 80.2 (15.3) 80.5 (15.5) 78.2 (12.9) 84.0 (19.8)
z log10PEF 1.45 (1.19) - 1.43 (1.23) 1.58 (1.05) 1.19 (1.29)
VC, %pred 93.7 (12.3) 94.2 (11.9) 93.2 (13.1) 91.4 (12.3)
z log10VC 0.98 (1.79) 0.91 (1.79) 0.98 (1.77) 1.47 (1.86)
TLC, %pred 97.1 (11.7) 96.8 (10.6) 97.6 (13,.3) 97.14 (14.9)
z log10TLC 0.52 (1.77) 0.54 (1.62) 0.42 (1.89) 0.63 (2.43)
FRC, %pred 92.5 (16.4) 91.9 (16.3) 91.9 (16.1) 98.4 (18.5)
z log10FRC 0.94 (1.82) 1.02 (1.83) 0.97 (1.73) 0.33 (2.05)
RV, %pred 109.4 (30.6) 106.4 (28.8) 113.9 (29.6) 116.9 (43.2)
z log10RV 0.25 (1.55) 0.11 (1.55) 0.51 (1.36) 0.47 (2)
RV/TLC %pred 110.2 (25.3) 107.6 (25.5) 114.0(22.1) 116.3 (31.8)
z RV/TLC 0.68 (1.69) 0.51 (1.70) 0.94 (1.49) 1.1 (2.15)
Raw, %pred 91.4 (27.1) 93.4 (28.1) 85.3 (23.7) 95.2 (27.7)
z log10Raw - 0.63 (1.37) 0.52 (1.36) 0.94 (1.32) 0.45 (1.56)
Exercise-induced BHR 62/150 (41) 40/96 (42) 15/40 (37) 7/14 (50)
Positive BD response 55/74 (74) 35/46 (76) 11/17 (65) 9/11 (82)
DLCO measurements
n/N 97/151 67/91 25/41 14-May
DLCO (mmole min1 kPa1) 5.15 (0.80) 5.19 (0.80) 5.10 (0.90) 4.96 (0.60)
DLCO %pred 95.2 (14.3) 95.2 (14.1) 95.6 (15.9) 93.8 (11.6)
KCO (mmole min1 kPa1 L1) 1.85 (0.20) 1.86 (0.23) 1.86 (0.17) 1.85 (0.10)
Values are given as mean (SD) or n/N(%) as appropriate.
FVC, forced vital capacity; FEV1, forced expiratory volume at 1 s; FEF25e75, mid forced expiratory flow; PEF, peak expiratory flow; VC,
vital capacity; TLC, total lung capacity; FRC, functional residual capacity; RV, residual volume; Raw, airways resistances; BHR, bronchial
hyperresponsiveness; BD, bronchodilator; DLCO, CO lung diffusing capacity; KCO, DLCO/VA with VA the alveolar volume.
Pulmonary outcome correlates after preterm birth 1971air trapping and 11% restrictive or mixed abnormalities.
These findings were similar between the subgroups (see
Fig. E2 in the Online Supplement). EIB (present in 41% of
participants) and BD response did not vary according to prior
BPD status (Table 3).
Only 97/151 investigated children could satisfactorily
perform the diffusion test using the single breath method:
the failure was primarily due to FVC too decreased to open
the gas admission. An analysis conducted on the participants
without missing data showed that the children who failed to
perform the test were of lower GA, with more prior BPD, had
received more postnatal steroids and their mothers had had
multiple births and more antenatal steroids (see Table E2 in
the Online Supplement). All the children with prior severe
BPDwere unable to perform the test. Thus, in the less severe
children who had successfully undergone the test, mean
DLCO values were within the normal range although 15.5% of
them presented DLCO levels below 80% predicted.
At the end of the clinical and functional evaluation, 44%
of the participants were given appropriate respiratory
medications.Factors associated with lung function abnormalities
at school-age
The analysis was performed in only 136 participants without
missing data: they did not differ from the non-analysed
subjects neither in terms of antenatal and neonatal con-
ditions nor in terms of respiratory status during early
childhood. Univariable analyses showed no significant as-
sociation between lung abnormalities and antenatal,
neonatal variables or respiratory events during early
childhood (Table 4). The analysis adjusted on GA, IUGR,
surfactant exposure and BPD, showed that exogenous sur-
factant treatment was independently associated with a
lower risk of lung abnormalities (Table 5). The association
between BPD and lung abnormalities at school age was not
significant, however prior BPD increased the risk of
restrictive or mixed abnormalities. Among the antenatal,
neonatal and early childhood respiratory characteristics,
IUGR and multiple births were independently associated
with the presence of post-exercise EIB at school age (Table
6). The exposure to domestic pets was significantly
Table 4 Univariable analyses for both restrictive and mixed lung abnormalities and obstructive with or without air trapping
lung abnormalities in school-aged children born at 32 weeks of gestation, in 1997e2001, Bordeaux, France.
Variables Restrictive and mixed
abnormalities
Obstructive with or
without air trapping
abnormalities
Global p value
OR 95% CI OR 95% CI
Neonatal and perinatal variables
GA  28 wks 2.04 [0.45; 9.20] 1.07 [0.41; 2.80] 0.63
BPD 2.67 [0.72; 9.89] 1.09 [0.51; 2.31] 0.33
Female sex 1.47 [0.40; 5.39] 0.56 [0.27;1.17] 0.17
IUGR 2.34 [0.51; 10.75] 1.8 [0.70; 4.62] 0.38
Chorioamnionitis 1.96 [0.54; 7.20] 1.04 [0.50; 2.14] 0.58
Maternal smoking during pregnancy 2.11 [0.44; 10.10] 1.01 [0.39; 2.65] 0.61
Antenatal steroids 3.92 [0.78; 19.73] 1.29 [0.63; 2.63] 0.24
Exogenous surfactant treatment 0.46 [0.12; 1.76] 0.55 [0.27; 1.12] 0.2
Mechanical ventilation 0.79 [0.20; 3.03] 1.06 [0.49; 2.27] 0.91
Postnatal steroids 1.17 [0.31; 4.5] 1.07 [0.51; 2.26] 0.97
Early childhood variables
Ever wheezing episodes
3e5 Episodes vs < 3 1.93 [0.41; 9.13] 1.72 [0.63; 4.67] 0.48
>5 Episodes vs < 3 0.37 [0.04; 3.26] 1.51 [0.66; 3.46]
Allergy 1.62 [0.29; 9.08] 2.1 [0.79; 5.58] 0.33
Smoke exposure during childhood 0.87 [0.23; 3.31] 1.16 [0.57; 2.37] 0.87
Pet exposure 0.63 [0.17; 2.33] 0.73 [0.35- 1.52] 0.63
GA, gestational age; BPD, bronchopulmonary dysplasia; IUGR, intrauterine growth retardation (NZ 136 for all the variables, except for
maternal smoking during pregnancy variable: N Z 118).
1972 M.-L. Choukroun et al.associated with a non-response to bronchodilators (see
Table E3 in the Online Supplement).
For the ex-preterm children who successfully performed
the diffusion test, a prior PDA was strongly associated with
a 20% decrease in DLCO (Table 7, see Table E4 in the Online
Supplement).Discussion
The present study shows a high prevalence of persistent
respiratory symptoms, mild lung function defects and EIB in
school-aged children born at 32 weeks of gestation. TheTable 5 Multivariate analyses for both restrictive and mixed lu
lung abnormalities in school-aged children born <32 weeks of ge
Variables Restrictive and mixed
abnormalities
OR 95% CI
GA  28 wks 1.58 [0.29; 8
BPD 6.11 [1.10; 3
IUGR 2.55 [0.51; 1
Exogenous surfactant treatment 0.15 [0.03; 0
OR, odds ratio; CI, confidence interval; GA, gestational age; BPD, bro
N Z 136 for all the variables.mean lung function parameters were indeed slightly
altered, but if we consider individual lung function, only
42% of the assessed children had normal lung function,
while 47% were obstructive, and 11% demonstrated
restrictive and/or mixed abnormalities. Although these
findings pertain to all ex-preterm children, respiratory
symptoms were more frequent in children with prior mod-
erate/severe BPD. Lung function abnormalities and EIB
were not different according to BPD status after birth
suggesting that moderate premature birth per se can cause
mildly reduced lung function and EIB during middle child-
hood. In the enrolled children of the present study, exog-
enous surfactant treatment at birth reduced the risk of anyng abnormalities and obstructive with or without air trapping
station, in 1997e2001, Bordeaux, France.
Obstructive with or
without air trapping
abnormalities
Global
p value
OR 95% CI
.68] 1.11 [0.38; 3.22] 0.87
3.99] 1.72 [0.65; 4.52] 0.11
2.84] 2.06 [0.78; 5.48] 0.29
.78] 0.38 [0.16; 0.91] 0.03
nchopulmonary dysplasia; IUGR, intrauterine growth retardation.
Table 6 Univariable and multivariable analyses for exercise-induced bronchial hyper-responsiveness in school-aged children
born 32 weeks of gestation in 1997e2001, Bordeaux, France.
Variables Univariable analysis Multivariable analysis
OR 95% CI p Value OR 95% CI p Value
Neonatal and perinatal variables
GA (28 weeks vs >28 weeks) 0.83 [0.33; 2.07] 0.68 1.24 [0.42; 3.67] 0.69
BPD 0.96 [0.46; 1.97] 0.9 0.71 [0.3; 1.69] 0.44
Sex 1.59 [0.79; 3.21] 0.19
Multiple births 2.15 [1.02; 4.54] 0.04 2.43 [1.07; 5.53] 0.03
IUGR 2.88 [1.17; 7.1] 0.02 3.02 [1.2; 7.59] 0.02
Chorioamnionitis 1.33 [0.66; 2.66] 0.43
Maternal smoking during pregnancy* 0.61 [0.24; 1.56] 0.3
Antenatal steroids 1.47 [0.73; 2.95] 0.28
Exogenous surfactant treatment 0.92 [0.47; 1.83] 0.82
Mechanical ventilation 1.01 [0.48; 2.1] 0.99
Duration of ventilation
<1 wk vs no ventilation 1.14 [0.52; 2.5] 0.7
1 wk vs no ventilation 0.77 [0.3; 2.02]
Duration of O2 therapy
<28 d vs no ventilation 1.03 [0.48; 2.23] 0.97
28 d vs no ventilation 0.92 [0.32; 2.63]
Postnatal steroids 0.96 [0.46; 1.97] 0.9
Early childhood variables
Wheezing episodes
3e5 episodes vs <3 1 [0.4; 2.54] 0.86
>5 episodes vs <3 1.25 [0.56; 2.81]
Hospitalisation for asthma (yes vs no) 7.17 [0.81; 63.1] 0.08
Allergy (yes vs no) 2.13 [0.87; 5.22] 0.1
Smoke exposure during childhood (yes vs no) 1.12 [0.56; 2.24] 0.74
Domestic pet exposure (yes vs no) 0.97 [0.48; 1.95] 0.93
GA, gestational age; BPD, bronchopulmonary dysplasia; IUGR, intrauterine growth retardation.
N Z 135 for all the variables, except for maternal smoking during pregnancy variable: N Z 117.
Pulmonary outcome correlates after preterm birth 1973lung function abnormalities at school age. BPD was not
significantly associated with lung abnormalities at school
age, but it increased the risk of restrictive or mixed ab-
normalities. IUGR and multiple births were independentlyTable 7 Multivariate analyses for a 20% decrease in DLCO
in school-aged children born at 32 weeks of gestation in
1997e2001, Bordeaux, France.
Variables 20% decreased DLCO
OR 95% CI p Value
GA  28 weeks 0.8 [0.11; 5.96] 0.83
BPD 0.52 [0.09; 2.99] 0.47
IUGR 1.66 [0.35; 7.96] 0.52
PDA 9.73 [2.00; 47.29] 0.01
DLCO, CO lung diffusing capacity; OR, odds ratio; CI, confidence
interval; GA, gestational age; BPD, bronchopulmonary
dysplasia; IUGR, intrauterine growth retardation; PDA, Patent
Ductus Arteriosus.
N Z 89 for all the variables.associated with EIB, and prior PDA with DLCO impairment at
school age. Respiratory events during infancy and early
childhood were not associated with the occurrence of lung
function abnormalities at school age. It should be noted
that these results present some limitations due to the small
number of children with prior moderate and severe BPD.
Surfactant-era data suggest that pre-adolescent pulmo-
nary outcome in EP newborns with low birth weights (LBW)
and VLBW is characterized by high rates of wheezing, cough
and asthma [8,20] especially when BPD was present. Our
study conducted in less preterm children showed similar
findings with respect to wheezing, nocturnal cough, and
exercise dyspnoea. However, current wheezing rates were
not increased compared to what is usually reported in our
geographical area, except for the children with prior
moderate/severe BPD [21].
In addition to respiratory symptoms, lung function
impairment has been reported in various studies [22,23]:
the mean baseline lung function of ex-preterm children
remained within the reference range although reduced
spirometry with possible mild air trapping was observed vs.
1974 M.-L. Choukroun et al.term controls. One weakness of our study arises from the
lack of a control group but our findings expressed in %
predicted were very similar to those relating moderate
persistent functional lung impairment during middle child-
hood. In our study, lung function was less reduced than in
previous reports conducted in ex-EP and VP infants [8]. This
can partly be explained by the use of the Zapletal refer-
ence equations which may underestimate reductions in
lung function [24]. Nevertheless, more than 50% of the
participants showed lung function abnormalities. As previ-
ously described [8], airway obstruction at school age
remained the main identified defect. Importantly, howev-
er, restrictive or mixed lung defects were present in 11% of
the children. The EPICure cohort data [9] reported a similar
proportion of restrictive lung abnormalities in ex-EP chil-
dren at 11 years. The expired airflow limitation may result
not only from airway obstruction but also from decreased
lung volumes with airways of reduced size.
In most studies, prematurity with prior BPD was associ-
ated with increased respiratory morbidity and worse lung
function than in the absence of BPD [8,20]. In the present
study, lung function did not significantly change according
to BPD severity. This could be attributed to the low number
of subjects with prior moderate/severe BPD despite the
fact that they were merged into a single group. Never-
theless, although the association between BPD and lung
abnormalities at school age was not significant e likely due
to a lack of statistical power e prior BPD increased the risk
of restrictive or mixed abnormalities. Indeed the “new”
BPD corresponds to an arrest of alveolar growth, therefore
restrictive or mixed lung defects can be expected in ex-
preterms with prior BPD. Small lung volumes measured in
some ex-preterm children suggest that alveolar growth may
not have completely caught-up at school age. The effect of
surfactant on respiratory outcome during childhood is still
debated [25,26]. In the present cohort where prophylactic
surfactant treatment was not standard therapy, the results
support its beneficial effects on lung function at school
age.
Up to 41% of the participants presented with significant
EIB. BHR to histamine or methacholine challenges is com-
mon in ex-preterm children in particular with prior BPD
[11,27]. Exercise challenge has rarely been used in ex-
preterm children, but it seems appropriate to investigate
respiratory symptoms as wheezing, cough, dyspnoea re-
ported during exercise. The mechanisms underlying BHR
observed after premature birth remain unclear. Halvorsen
et al. [28] demonstrated that they differ from typical
asthma, and that they are related to a neonatal history of
BPD and prolonged oxygen supplementation. In the present
cohort, EIB incidence differed from asthma incidence
pointing to mechanisms other than in asthma as suggested
by Baraldi data [29]. However, we did not identify any in-
fluence of mechanical ventilation or oxygen treatment on
EIB, while IUGR and multiple births were associated with
the presence of EIB. In full-term children, Kotecha et al [30]
reported that IUGR was associated with reduced lung
function at 8e9 years, but not with increased BHR. This
suggests an additional effect of prematurity and IUGR on
BHR. A non-response to BD was mostly influenced by the
presence of domestic pets which was more frequent in
children with moderate/severe BPD. However othermeasurements including more children are required to
investigate the BD response in this group.
No environmental factors including tobacco smoke
exposure were associated with abnormal lung function.
Exposure to maternal smoking during pregnancy may have
adverse effects on alveolar lung growth and lung function
during childhood [31]. We did not observe any impact of
this variable on lung function at school age but the power of
the present analysis may be limited due to the large
amount of missing data for this variable. Exposure to fa-
milial tobacco smoke was not associated with participant
lung function abnormalities, although this variable was well
recorded. This has previously been reported in ex-preterm
children [8,30] suggesting different lung susceptibility to
tobacco between term and preterm children.
Reduced DLCO has been reported in ex-preterms with
BPD [8,32]. In our cohort, in agreement with Smith et al
[22], DLCO was unaltered in most children, however these
results are not representative of all the included children
but only of those without or with mild BPD: the children
with prior severe BPD could not perform the test. In this
population without or with prior mild BPD, the presence of
PDA at birth was associated with a 20% reduction in DLCO.
This may have resulted from reduced alveolar volume,
alveolar capillary membrane impairment, and/or a reduced
capillary bed. Decreased DLCO adjusted for alveolar vol-
ume described by Balinotti et al. [33] in infants and tod-
dlers with chronic lung disease suggests alveolar and
vascular growth impairment after very premature birth. In
baboons, PDA induces alveolar development arrest and
reduced alveolar surface area [34]. In preterms, the
increased pulmonary blood flow resulting from a PDA
through an immature pulmonary vascular bed may produce
vascular lung injury and alveolar growth arrest [35]. Our
results suggest that alveolar capillary catch-up growth was
not complete in ex-preterm children with prior PDA. How-
ever more measurements including children with prior se-
vere BPD are required to conclude.
Overall, the present findings probably underestimate the
severity of lung function impairments of school-aged chil-
dren born with a GA  32weeks. Despite the fact that the
participants were representative of the excluded surviving
cohort with respect to GA, BW and prior BPD status, at birth
they demonstrated less respiratory distress, less PDA, and
less mechanical ventilation suggesting less severe neonatal
disease and most probably better pulmonary outcome than
in this cohort.Conclusion
Respiratory morbidity and mild lung function impairment
with EIB are prevalent at mid-childhood in children born
with a GA  32weeks. Surfactant therapy at birth was
independently associated with a significantly lower risk of
any lung abnormalities. By contrast children with prior BPD
remained at risk of restrictive or mixed lung abnormalities.
The presence of a prior PDA was associated with DLCO
impairments. Surprisingly, postnatal environmental factors
appeared to have a limited impact on the respiratory
outcome. Given the limitations related to the small number
of children with prior severe BPD, both obstructive and/or
Pulmonary outcome correlates after preterm birth 1975restrictive lung defects reported in the present study may
warrant more active follow-up in all children born with
intermediate prematurity. Accurate evaluation of the res-
piratory status of all ex-preterm children, irrespective of
the presence or absence of prior BPD, may promote earlier
respiratory interventions in order to reduce the risk of
greater lung impairment later in life.
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